Augmedics Secures $8.3M in Series A Funding

Augmedics, a Yokneam, Israel-based developer of an augmented-reality (AR) surgical visualization system, secured $8.3m in Series A funding.

The round was led by AO Invest, Israeli Innovation Authority, Terra Venture Partners and other undisclosed investors.

The company will use the proceeds to complete research and development as well as pre-clinical and clinical trials of its ViZOR System, establish strategic distribution partnerships, and seek 510(k) clearance for The ViZOR from the US. Food and Drug Administration.

Founded in 2014 by Nissan Elimelech, CEO, Augmedics has developed the ViZOR System, an augmented reality surgical visualization solution designed to allow surgeons to see inside a patient’s anatomy during complex procedures. First intended for use in minimally invasive spinal surgery, The ViZOR can help improve procedures by allowing surgeons to see the patient’s spine through skin and tissue, as if they had X-ray vision, eliminating some of the limitations of minimally invasive spine surgery.
The ViZOR uses proprietary patented see-through AR optics to project a 3D image of a patient’s spine onto a surgeon’s retina, in real-time, with surgical precision and outstanding depth perception.
In the future, the system will leverage various sensors to collect big surgical data to process and analyze using deep learning algorithms. Ultimately, it will also make suggestions, provide alerts, and perform other surgical assistance during the procedure.



Join the discussion